Chemotherapy Induced Peripheral Neuropathy Treatment Market Status and Forecast in Global by Product Type and End-user and Regions(Countries) 2016-2026 (COVID-19 Version)

SKU ID :99ST-18243614 | Published Date: 10-May-2021 | No. of pages: 174
TABLE OF CONTENTS 1 INDUSTRY OVERVIEW 1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Industry 1.1.1 Chemotherapy Induced Peripheral Neuropathy Treatment Overview 1.1.2 Terminology Definition in the Report 1.1.2.1 Capacity 1.1.2.2 Sales Volume 1.1.2.3 Sales Revenue 1.1.2.4 Ex-factory Price & Sales Price 1.1.2.5 Cost 1.1.2.6 Gross Margin 1.2 Products & Services Overview Scope 1.3 Chemotherapy Induced Peripheral Neuropathy Treatment in the Industry Chain 1.4 Industry Dynamics & Regulations 1.5 Global Market Overview 2 UPSTREAM & MANUFACTURING 2.1 Raw Materials / Components 2.2 Procurement Methods & Channels 2.3 Cost Structure & Manufacturing 2.4 Industry Capacity Overview 2.5 Production Distribution by Geography 2.5.1 Production in Major Regions / Countries 2.5.2 Trade Flow Overview 3 PRODUCT SEGMENT 3.1 Product Segmentation Market (2017 to 2021E) 3.1.1 APX-3330 Market 3.1.2 BR-297 Market 3.1.3 Cannabidiol Market 3.1.4 Dimiracetam Market 3.1.5 Others Market 3.2 Market Status 4 APPLICATION / END-USE SEGMENT 4.1 Application Segmentation Market (2016 to 2021E) 4.1.1 Clinic Market 4.1.2 Hospital Market 4.1.3 Others Market 4.2 Market Status 5 NORTH AMERICA 5.1 North America Market Growth 5.2 North America Market by Countries 5.3 Major Countries Market Growth 5.3.1 United States Market Size and Growth (2016-2021E) 5.3.2 Canada Market Size and Growth (2016-2021E) 5.3.3 Mexico Market Size and Growth (2016-2021E) 6 EUROPE 6.1 Europe Market Growth 6.2 Europe Market by Countries 6.3 Major Countries Market Growth 6.3.1 Germany Market Size and Growth (2016-2021E) 6.3.2 UK Market Size and Growth (2016-2021E) 6.3.3 France Market Size and Growth (2016-2021E) 6.3.4 Russia Market Size and Growth (2016-2021E) 6.3.5 Italy Market Size and Growth (2016-2021E) 6.3.6 Rest of Europe Market Size and Growth (2016-2021E) 7 ASIA-PACIFIC 7.1 ASIA-PACIFIC Market Growth 7.2 ASIA-PACIFIC Market by Countries 7.3 Major Countries Market Growth 7.3.1 China Market Size and Growth (2016-2021E) 7.3.2 India Market Size and Growth (2016-2021E) 7.3.3 Japan Market Size and Growth (2016-2021E) 7.3.4 South Korea Market Size and Growth (2016-2021E) 7.3.5 Southeast Asia Market Size and Growth (2016-2021E) 7.3.6 Australia Market Size and Growth (2016-2021E) 7.3.7 Rest of Asia Pacific Market Size and Growth (2016-2021E) 8 SOUTH AMERICA 8.1 South America Market Growth 8.2 South America Market by Countries 8.3 Major Countries Market Growth 8.3.1 Brazil Market Size and Growth (2016-2021E) 8.3.2 Argentina Market Size and Growth (2016-2021E) 8.3.3 Rest of South America Market Size and Growth (2016-2021E) 9 MIDDLE EAST & AFRICA 9.1 Middle East and Africa Market Growth 9.2 Middle East and Africa Market by Countries 9.3 Major Countries Market Growth 9.3.1 GCC Market Size and Growth (2016-2021E) 9.3.2 North Africa Market Size and Growth (2016-2021E) 9.3.3 South Africa Market Size and Growth (2016-2021E) 9.3.4 Rest of Middle East & Africa Market Size and Growth (2016-2021E) 10 MARKET FORECAST 10.1 Global Market Forecast Overview 10.2 Global Market Forecast by Type 10.3 Global Market Forecast by Application / End-Use 10.4 Global Market Forecast by Region 11 COMPETITION OF MAJOR PLAYERS 11.1 Achelios Therapeutics Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.1.1 Achelios Therapeutics Inc Profile 11.1.2 Achelios Therapeutics Inc Products & Services Overview 11.1.3 Achelios Therapeutics Inc Main Business 11.1.4 Achelios Therapeutics Inc Business Operation 11.2 Advinus Therapeutics Ltd (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.2.1 Advinus Therapeutics Ltd Profile 11.2.2 Advinus Therapeutics Ltd Products & Services 11.2.3 Advinus Therapeutics Ltd Main Business 11.2.4 Advinus Therapeutics Ltd Business Operation 11.3 Apollo Endosurgery Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.3.1 Apollo Endosurgery Inc Profile 11.3.2 Apollo Endosurgery Inc Products & Services 11.3.3 Apollo Endosurgery Inc Main Business 11.3.4 Apollo Endosurgery Inc Business Operation 11.4 Aptinyx Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.4.1 Aptinyx Inc Profile 11.4.2 Aptinyx Inc Products & Services 11.4.3 Aptinyx Inc Main Business 11.4.4 Aptinyx Inc Business Operation 11.5 Asahi Kasei Pharma Corp (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.5.1 Asahi Kasei Pharma Corp Profile 11.5.2 Asahi Kasei Pharma Corp Products & Services 11.5.3 Asahi Kasei Pharma Corp Main Business 11.5.4 Asahi Kasei Pharma Corp Business Operation 11.6 Can-Fite BioPharma Ltd (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.6.1 Can-Fite BioPharma Ltd Profile 11.6.2 Can-Fite BioPharma Ltd Products & Services 11.6.3 Can-Fite BioPharma Ltd Main Business 11.6.4 Can-Fite BioPharma Ltd Business Operation 11.7 Celgene Corp (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.7.1 Celgene Corp Profile 11.7.2 Celgene Corp Products & Services 11.7.3 Celgene Corp Main Business 11.7.4 Celgene Corp Business Operation 11.8 DermaXon LLC (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.8.1 DermaXon LLC Profile 11.8.2 DermaXon LLC Products & Services 11.8.3 DermaXon LLC Main Business 11.8.4 DermaXon LLC Business Operation 11.9 Eisai (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.9.1 Eisai Profile 11.9.2 Eisai Products & Services 11.9.3 Eisai Main Business 11.9.4 Eisai Business Operation 11.10 Immune Pharmaceuticals Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.10.1 Immune Pharmaceuticals Inc Profile 11.10.2 Immune Pharmaceuticals Inc Products & Services 11.10.3 Immune Pharmaceuticals Inc Main Business 11.10.4 Immune Pharmaceuticals Inc Business Operation 11.11 INSYS Therapeutics Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.11.1 INSYS Therapeutics Inc Profile 11.11.2 INSYS Therapeutics Inc Products & Services 11.11.3 INSYS Therapeutics Inc Main Business 11.11.4 INSYS Therapeutics Inc Business Operation 11.12 Kineta Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.12.1 Kineta Inc Profile 11.12.2 Kineta Inc Products & Services 11.12.3 Kineta Inc Main Business 11.12.4 Kineta Inc Business Operation 11.13 KPI Therapeutics Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.13.1 KPI Therapeutics Inc Profile 11.13.2 KPI Therapeutics Inc Products & Services 11.13.3 KPI Therapeutics Inc Main Business 11.13.4 KPI Therapeutics Inc Business Operation 11.14 Krenitsky Pharmaceuticals Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.14.1 Krenitsky Pharmaceuticals Inc Profile 11.14.2 Krenitsky Pharmaceuticals Inc Products & Services 11.14.3 Krenitsky Pharmaceuticals Inc Main Business 11.14.4 Krenitsky Pharmaceuticals Inc Business Operation 11.15 MAKScientific LLC (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.15.1 MAKScientific LLC Profile 11.15.2 MAKScientific LLC Products & Services 11.15.3 MAKScientific LLC Main Business 11.15.4 MAKScientific LLC Business Operation 11.16 Metys Pharmaceuticals AG (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.16.1 Metys Pharmaceuticals AG Profile 11.16.2 Metys Pharmaceuticals AG Products & Services 11.16.3 Metys Pharmaceuticals AG Main Business 11.16.4 Metys Pharmaceuticals AG Business Operation 11.17 Midatech Pharma US Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.17.1 Midatech Pharma US Inc Profile 11.17.2 Midatech Pharma US Inc Products & Services 11.17.3 Midatech Pharma US Inc Main Business 11.17.4 Midatech Pharma US Inc Business Operation 11.18 Mundipharma International Ltd (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.18.1 Mundipharma International Ltd Profile 11.18.2 Mundipharma International Ltd Products & Services 11.18.3 Mundipharma International Ltd Main Business 11.18.4 Mundipharma International Ltd Business Operation 11.19 Nemus Bioscience Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.19.1 Nemus Bioscience Inc Profile 11.19.2 Nemus Bioscience Inc Products & Services 11.19.3 Nemus Bioscience Inc Main Business 11.19.4 Nemus Bioscience Inc Business Operation 11.20 Neurocentrx Pharma Ltd (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.20.1 Neurocentrx Pharma Ltd Profile 11.20.2 Neurocentrx Pharma Ltd Products & Services 11.20.3 Neurocentrx Pharma Ltd Main Business 11.20.4 Neurocentrx Pharma Ltd Business Operation 11.21 Panacea Pharmaceuticals Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.21.1 Panacea Pharmaceuticals Inc Profile 11.21.2 Panacea Pharmaceuticals Inc Products & Services 11.21.3 Panacea Pharmaceuticals Inc Main Business 11.21.4 Panacea Pharmaceuticals Inc Business Operation 11.22 PeriphaGen Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.22.1 PeriphaGen Inc Profile 11.22.2 PeriphaGen Inc Products & Services 11.22.3 PeriphaGen Inc Main Business 11.22.4 PeriphaGen Inc Business Operation 11.23 PharmatrophiX Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.23.1 PharmatrophiX Inc Profile 11.23.2 PharmatrophiX Inc Products & Services 11.23.3 PharmatrophiX Inc Main Business 11.23.4 PharmatrophiX Inc Business Operation 11.24 PledPharma AB (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.24.1 PledPharma AB Profile 11.24.2 PledPharma AB Products & Services 11.24.3 PledPharma AB Main Business 11.24.4 PledPharma AB Business Operation 11.25 Sova Pharmaceuticals Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.25.1 Sova Pharmaceuticals Inc Profile 11.25.2 Sova Pharmaceuticals Inc Products & Services 11.25.3 Sova Pharmaceuticals Inc Main Business 11.25.4 Sova Pharmaceuticals Inc Business Operation 11.26 Virobay Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.26.1 Virobay Inc Profile 11.26.2 Virobay Inc Products & Services 11.26.3 Virobay Inc Main Business 11.26.4 Virobay Inc Business Operation 11.27 WEX Pharmaceuticals Inc (Company Profile, Products Overview, Sales Data, Latest Developments etc.) 11.27.1 WEX Pharmaceuticals Inc Profile 11.27.2 WEX Pharmaceuticals Inc Products & Services 11.27.3 WEX Pharmaceuticals Inc Main Business 11.27.4 WEX Pharmaceuticals Inc Business Operation 12 COMPANY COMPETITION 12.1 Global Sales by Company 12.1.1 Global Sales by Company 12.1.2 Global Sales Share by Company 12.2 Price & Gross Margin 12.3 Landscape of Major Companies in the Market 12.3.1 Major Companies Product Type List 12.3.1 Manufacturing Regions and Headquarters of Major Companies 12.3.1 Mergers & Acquisitions 12.4 Competitive Environment for New Entrants 12.4.1 Michael Porter's Five Forces Model 12.4.2 SWOT 13 ENVIRONMENT OVERVIEW 13.1 Impact of COVID-19 13.2 Geopolitics Overview 13.3 Economic Overview of Major Countries 14 RESEARCH CONCLUSION
LIST OF TABLE TABLE ~ Chemotherapy Induced Peripheral Neuropathy Treatment Industry Dynamics & Regulations List TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Volume, Revenue, Price, Cost and Margin, 2016-2021E TABLE ~ APX-3330 Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ APX-3330 Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ BR-297 Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ BR-297 Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Cannabidiol Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Cannabidiol Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Dimiracetam Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Dimiracetam Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type, 2016-2021E, in Volume TABLE ~ Clinic Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Clinic Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Hospital Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Hospital Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Others Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Others Market Size (Volume) 2016-2021E and Year-over-year (YOY) Growth (%) 2017-2021E TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type, 2016-2021E, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size by Type, 2016-2021E, in Volume TABLE ~ North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in USD Million TABLE ~ North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in USD Million TABLE ~ North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in Volume TABLE ~ North America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in Volume TABLE ~ United States Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Canada Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Mexico Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in USD Million TABLE ~ Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in Volume TABLE ~ Europe Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in Volume TABLE ~ Germany Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ UK Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ France Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Russia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Italy Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Europe Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ ASIA-PACIFIC Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in USD Million TABLE ~ ASIA-PACIFIC Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in Volume TABLE ~ ASIA-PACIFIC Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in Volume TABLE ~ China Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ India Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Japan Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Korea Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Southeast Asia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Australia Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Asia Pacific Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in USD Million TABLE ~ South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in USD Million TABLE ~ South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in Volume TABLE ~ South America Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in Volume TABLE ~ Brazil Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Argentina Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of South America Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in USD Million TABLE ~ Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Countries 2016-2021E, in Volume TABLE ~ Middle East and Africa Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Countries 2016-2021E, in Volume TABLE ~ GCC Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ North Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ South Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Rest of Middle East & Africa Market Size (USD Million & Volume), Pric (USD/Volume) 2016-2021E TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Type 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Type 2022F-2026F, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Application / End-Use 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Application / End-Use 2022F-2026F, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Region 2022F-2026F, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Forecast by Region 2022F-2026F, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share Forecast by Region 2022F-2026F, in Volume TABLE ~ Achelios Therapeutics Inc Overview List TABLE ~ Products & Services List of Achelios Therapeutics Inc TABLE ~ Business Operation of Achelios Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Advinus Therapeutics Ltd Overview List TABLE ~ Products & Services List of Advinus Therapeutics Ltd TABLE ~ Business Operation of Advinus Therapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Apollo Endosurgery Inc Overview List TABLE ~ Products & Services List of Apollo Endosurgery Inc TABLE ~ Business Operation of Apollo Endosurgery Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Aptinyx Inc Overview List TABLE ~ Products & Services List of Aptinyx Inc TABLE ~ Business Operation of Aptinyx Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Asahi Kasei Pharma Corp Overview List TABLE ~ Products & Services List of Asahi Kasei Pharma Corp TABLE ~ Business Operation of Asahi Kasei Pharma Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Can-Fite BioPharma Ltd Overview List TABLE ~ Products & Services List of Can-Fite BioPharma Ltd TABLE ~ Business Operation of Can-Fite BioPharma Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Celgene Corp Overview List TABLE ~ Products & Services List of Celgene Corp TABLE ~ Business Operation of Celgene Corp (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ DermaXon LLC Overview List TABLE ~ Products & Services List of DermaXon LLC TABLE ~ Business Operation of DermaXon LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Eisai Overview List TABLE ~ Products & Services List of Eisai TABLE ~ Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Immune Pharmaceuticals Inc Overview List TABLE ~ Products & Services List of Immune Pharmaceuticals Inc TABLE ~ Business Operation of Immune Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ INSYS Therapeutics Inc Overview List TABLE ~ Products & Services List of INSYS Therapeutics Inc TABLE ~ Business Operation of INSYS Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Kineta Inc Overview List TABLE ~ Products & Services List of Kineta Inc TABLE ~ Business Operation of Kineta Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ KPI Therapeutics Inc Overview List TABLE ~ Products & Services List of KPI Therapeutics Inc TABLE ~ Business Operation of KPI Therapeutics Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) TABLE ~ Krenitsky Pharmaceuticals Inc Overview List TABLE ~ Products & Services List of Krenitsky Pharmaceuticals Inc TABLE ~ Business Operation of Krenitsky Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ MAKScientific LLC Overview List TABLE ~ Products & Services List of MAKScientific LLC TABLE ~ Business Operation of MAKScientific LLC (Sales Revenue, Cost, Gross Margin) TABLE ~ Metys Pharmaceuticals AG Overview List TABLE ~ Products & Services List of Metys Pharmaceuticals AG TABLE ~ Business Operation of Metys Pharmaceuticals AG (Sales Revenue, Cost, Gross Margin) TABLE ~ Midatech Pharma US Inc Overview List TABLE ~ Products & Services List of Midatech Pharma US Inc TABLE ~ Business Operation of Midatech Pharma US Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ Mundipharma International Ltd Overview List TABLE ~ Products & Services List of Mundipharma International Ltd TABLE ~ Business Operation of Mundipharma International Ltd (Sales Revenue, Cost, Gross Margin) TABLE ~ Nemus Bioscience Inc Overview List TABLE ~ Products & Services List of Nemus Bioscience Inc TABLE ~ Business Operation of Nemus Bioscience Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ Neurocentrx Pharma Ltd Overview List TABLE ~ Products & Services List of Neurocentrx Pharma Ltd TABLE ~ Business Operation of Neurocentrx Pharma Ltd (Sales Revenue, Cost, Gross Margin) TABLE ~ Panacea Pharmaceuticals Inc Overview List TABLE ~ Products & Services List of Panacea Pharmaceuticals Inc TABLE ~ Business Operation of Panacea Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ PeriphaGen Inc Overview List TABLE ~ Products & Services List of PeriphaGen Inc TABLE ~ Business Operation of PeriphaGen Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ PharmatrophiX Inc Overview List TABLE ~ Products & Services List of PharmatrophiX Inc TABLE ~ Business Operation of PharmatrophiX Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ PledPharma AB Overview List TABLE ~ Products & Services List of PledPharma AB TABLE ~ Business Operation of PledPharma AB (Sales Revenue, Cost, Gross Margin) TABLE ~ Sova Pharmaceuticals Inc Overview List TABLE ~ Products & Services List of Sova Pharmaceuticals Inc TABLE ~ Business Operation of Sova Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ Virobay Inc Overview List TABLE ~ Products & Services List of Virobay Inc TABLE ~ Business Operation of Virobay Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ WEX Pharmaceuticals Inc Overview List TABLE ~ Products & Services List of WEX Pharmaceuticals Inc TABLE ~ Business Operation of WEX Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin) TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Company 2016-2021E, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales by Company 2016-2021E, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Company 2016-2021E, in USD Million TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Share by Company 2016-2021E, in Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Sales Price by Company 2016-2021E, in USD/Volume TABLE ~ Global Chemotherapy Induced Peripheral Neuropathy Treatment Gross Margin by Company 2016-2021E TABLE ~ Major Companies Product Type List TABLE ~ Major Companies Product Type List TABLE ~ Mergers & Acquisitions in the Market
  • PRICE
  • $3250
    $6500
    Buy Now

Our Clients